secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001104659-24-048576
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics appoints Felix Baker to board; Jordan resigns, becomes consultant
--------------------------------------------------------------------------------

- Veronica Jordan resigned as director April 17; will serve as consultant at GBP 12,000/yr for 2-year term, equity continues vesting.
- Felix J. Baker appointed as Class I director effective April 18; will sit on Nominating and Scientific committees.
- BBA Funds (Baker's affiliates) obtained registration rights for resale of ordinary shares/ADSs; company to file registration within 60 days of demand.
- BBA Funds hold >10% of outstanding shares; Baker is a managing member of Baker Bros. Advisors GP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/0001104659-24-048576-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/tm2412008d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-048576

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer